Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort

In lymphangioleiomyomatosis patients receiving sirolimus treatment, transient leukopenia in the morning may be due to circadian rhythm, with leukocyte counts recovering later in the day, indicating that a decrease in drug dose may not be warranted http://ow.ly/jPFz30iysgV

Detalles Bibliográficos
Autores principales: Gopalakrishnan, Vissagan, Jones, Amanda M., Julien-Williams, Patricia, Machado, Tania, Danner, Robert L., Swigris, Jeffrey J., Paine, Robert, Lozier, Jay N., Moss, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Original Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862345/
https://www.ncbi.nlm.nih.gov/pubmed/29577040
http://dx.doi.org/10.1183/23120541.00121-2017
Descripción
Sumario:In lymphangioleiomyomatosis patients receiving sirolimus treatment, transient leukopenia in the morning may be due to circadian rhythm, with leukocyte counts recovering later in the day, indicating that a decrease in drug dose may not be warranted http://ow.ly/jPFz30iysgV

Ejemplares similares